Stockholm - Delayed Quote SEK
Lipum AB (publ) (LIPUM.ST)
At close: November 6 at 1:32 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-77,612.00
-36,126.00
-52,406.00
-34,296.00
-19,370.00
Investing Cash Flow
--
-188.00
-60.00
--
--
Financing Cash Flow
72,935.00
13,703.00
38,250.00
76,909.00
8,456.00
End Cash Position
12,874.00
10,226.00
32,837.00
47,053.00
4,440.00
Capital Expenditure
--
-188.00
-60.00
--
--
Issuance of Capital Stock
79,715.00
15,276.00
39,161.00
85,701.00
8,456.00
Free Cash Flow
-77,612.00
-36,314.00
-52,466.00
-34,296.00
-19,370.00
12/31/2020 - 4/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AZT.OL ArcticZymes Technologies ASA
13.80
-19.11%
DIABIO.ST Diagonal Bio AB (publ)
0.0319
-4.20%
TRMED.OL Thor Medical ASA
1.4280
-1.38%
IMMU.ST Mendus AB (publ)
10.55
+0.67%
CRNA.OL Circio Holding ASA
0.9180
-3.37%
ADXN Addex Therapeutics Ltd
11.01
+2.13%
TRVI Trevi Therapeutics, Inc.
3.1000
+2.65%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.9766
+8.26%
CMND Clearmind Medicine Inc.
1.3500
-4.26%
OCEA Ocean Biomedical, Inc.
0.8799
+3.52%